Bioabsorbable Stents Market - Top Companies and Manufacturers

Companies Dominating the Bioabsorbable Stents Landscape

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global bioabsorbable stents market that are included in our report are

Abbott
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Elixir Medical Corporation
BIOTRONIK SE & Co KG
Arterius Limited
Boston Scientific Corporation
Meril Life Sciences Pvt. Ltd.,
OrbusNeich Medical Company Limited
Lepu Medical Technology (Beijing) Co., Ltd.

Browse Key Market Insights with Data Illustration:

Bioabsorbable Stents Market Size & Share, Growth Trends 2036

In the News

July 27^th, 2021: Boston Scientific Corporation, in its second quarter financial announcements, stated that during this quarter, the company enrolled itself in the AGENT IDE trial in the U.S., which was a first randomized study designed to assess safety and effectiveness of plain old balloon angioplasty (POBA) with AGENT Drug Coated Balloon in patients with in-stent restenosis.
June 30^th, 2021: Abbott announced that it has received approval for one-month DAPT labeling for high bleeding risk (HBR) patients in the U.S. from the U.S. Food and Drug Administration (FDA) for its XIENCE family of stents. Moreover, it has also received European CE Mark approval and FDA approval for XIENCE Skypoint stent, which is a next-generation stent for use in HBR patients.

Frequently Asked Questions (FAQ)

The increasing prevalence of cardiovascular diseases (cvds) and the rising focus of the government of nations to facilitate advance healthcare infrastructure are some of the major factors anticipated to drive the market growth.

The market is anticipated to attain a CAGR of 7.67% over the forecast period, i.e., 2021 â€“ 2030.

The lack of skilled professionals for using stents and the availability of low-cost alternatives are estimated to hamper the market growth.

The market in Europe region is anticipated to garner the largest revenue of USD 252.3 Million by the end of 2030 and display significant business opportunities for market growth.

The major players in the market are Abbott, Elixir Medical Corporation, BIOTRONIK SE & Co KG, Arterius Limited, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.

Bioabsorbable Stents Market - Top Companies and Manufacturers

Companies Dominating the Bioabsorbable Stents Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the bioabsorbable stents market?

What would be the CAGR of bioabsorbable stents market over the forecast period?

What are the challenges affecting the bioabsorbable stents market growth?

Which region will provide more business opportunities for growth of bioabsorbable stents market in future?

Who are the major players dominating the bioabsorbable stents market?